The revenue stands at ₹632.62 crore, reflecting a quarter-on-quarter *(QoQ) increase of 10.00 per cent from ₹575.12 crore. This corresponds to a year-on-year *(YoY) growth of 20.13 per cent.
Operating Profit stands at ₹69.94 crore, reflecting a quarter-on-quarter *(QoQ) increase of 98.02 per cent from ₹35.32 crore. This corresponds to a year-on-year *(YoY) growth of 210.98 per cent.
PBDT stands at ₹78.93 crore, reflecting a quarter-on-quarter *(QoQ) increase of 59.78 per cent from ₹49.40 crore. This corresponds to a year-on-year *(YoY) growth of 246.64 per cent.
Profit Before Tax stands at ₹48.99 crore, reflecting a quarter-on-quarter *(QoQ) increase of 160.72 per cent from ₹18.79 crore. This corresponds to a year-on-year *(YoY) growth of 643.13 per cent.
Net Profit stands at ₹41.47 crore, reflecting a quarter-on-quarter *(QoQ) increase of 280.11 per cent from ₹10.91 crore. This represents a 496.08 per cent year-on-year *(YoY) growth for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Unichem Labs. | 0.83% | -0.40% | -1.46% | -11.30% | 57.10% | 11.00% |
| SMS Pharma. | -0.99% | -6.89% | -4.31% | 11.17% | 6.65% | 58.59% |
| Gufic BioScience | 0.61% | -3.75% | -4.58% | 1.17% | 32.27% | 10.53% |
| Aarti Drugs | -0.94% | -0.51% | -3.56% | 4.56% | 17.03% | -19.44% |
| Kwality Pharma | 0.93% | -2.16% | -2.19% | 34.08% | 137.66% | 313.04% |
| Ind-Swift Labs. | -1.58% | -5.95% | -6.48% | 51.50% | 159.22% | 236.35% |
| Solara Active | -1.68% | -4.61% | -13.85% | 10.21% | 32.42% | 8.39% |
Chairman(Non Exe)&Dir(Non-Ind) : Prakash A Mody
Managing Director & CEO : Pabitra Bhattacharya
Non-Exec & Non-Independent Dir : Pranay Godha
Independent Non Exe. Director : Anand T Kusre
Independent Non Exe. Director : Arun Todarwal
Independent Non Exe. Director : Swati Patankar
HEAD - LEGAL / CS / CHIEF COMPLIANCE OFFICER : Pradeep Bhandari